Answers are grounded in this paper and cite their sources.
Magnoliae Flos and Centipeda Herba are classic herbal medicines for allergic rhinitis in traditional Chinese medicine, yet conventional nasal drops suffer from rapid clearance by nasal mucocilia, leading to limited nasal residence time. Herein, a thermosensitive in situ gel loaded with Magnoliae Flos and Centipeda Herba extract (MFCH-TGL) was fabricated to achieve prolonged, safe intranasal delivery. The gel matrix was composed of 17% (w/v) poloxamer 407 and 1% (w/v) poloxamer 188, incorporated with 2.3% (w/v) alcoholic extract and 0.5% (v/v) volatile oil of MFCH. We systematically characterized sol-gel transition performance, rheological behavior, in vitro release and ex vivo nasal permeation, and further assessed anti-allergic pharmacodynamics in BALB/c mice as well as nasal pharmacokinetics in SD rats. The formulation exhibited a sol–gel transition at 33.5 °C within 17 s, with 40.6 ± 1.97% cumulative nasal permeation over 8 h. Medium-dose MFCH-TGL markedly reduced OVA-specific IgE (8.28 ± 1.64, P < 0.01) compared with the allergic model group (12.55 ± 1.86). Moreover, the gel displayed 1.46-fold longer half-life and 1.52-fold longer mean residence time than the MFCH aqueous solution. This thermosensitive in situ gel presents promising intranasal application potential, offering a feasible formulation strategy for traditional Chinese medicine against allergic rhinitis.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: